Literature DB >> 28004164

Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.

Chien-Fang Huang1, Ju-Chi Liu2,3, Hui-Chuan Huang4,5, Shao-Yuan Chuang6, Chang-I Chen7,8, Kuan-Chia Lin9.   

Abstract

The aim of the study was to investigate the longitudinal transition trajectory of gout and its comorbidities in male patients with gout in different age groups. A total of 3973 male patients who received a new diagnosis of gouty arthritis were identified from the Taiwan Longitudinal Health Insurance Database and divided into two age cohorts (<50 and ≥50 years). Each patient was individually followed from 2000 to 2009 to identify associated comorbidities, namely hypertension, hypercholesterolemia, diabetes mellitus, cardiovascular diseases, and chronic kidney disease. Two outcome measurements of stroke and all-cause cancer were further identified until 2010. The transition trajectory was divided into the following five phenotype groups: persistent hypertension combined with a high prevalence of various gout-related comorbidities, persistent hypercholesterolemia combined with a moderate prevalence of various gout-related comorbidities, persistent low prevalence of various gout-related comorbidities, moderate to high prevalence of various gout-related comorbidities, and low to high prevalence of various gout-related comorbidities. Although the younger and older patients had a similar longitudinal transition trajectory of gout-related comorbidities, the older patients had a higher 10-year likelihood of transition from a low or moderate to a high prevalence of various gout-related comorbidities. In addition, the incidences of stroke and all-cause cancer were higher in the groups with high and moderate to high prevalences of various gout-related comorbidities than in the other groups. The occurrence of gouty arthritis in different life stages can cause cluster effects involving varying degrees of comorbidities over time. The findings of the current study can provide additional knowledge and increase clinical awareness regarding the early assessment and management of gout-related comorbidities in clinical practice.

Entities:  

Keywords:  Cancer; Comorbidities; Gout; Latent transition analysis; Stroke

Mesh:

Year:  2016        PMID: 28004164     DOI: 10.1007/s00296-016-3634-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

Review 1.  Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.

Authors:  Wolfram Doehner; Ulf Landmesser
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 2.  Chronic gout: epidemiology, disease progression, treatment and disease burden.

Authors:  Richard A Brook; Anna Forsythe; James E Smeeding; N Lawrence Edwards
Journal:  Curr Med Res Opin       Date:  2010-11-04       Impact factor: 2.580

3.  Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.

Authors:  Shao-Yuan Chuang; Shu-Chen Lee; Yao-Te Hsieh; Wen-Harn Pan
Journal:  Asia Pac J Clin Nutr       Date:  2011       Impact factor: 1.662

Review 4.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

Review 5.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

6.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

7.  Gout in women: differences in risk factors in young and older women.

Authors:  Sunil Kumar; Rajiv Gupta; Ravi Suppiah
Journal:  N Z Med J       Date:  2012-10-12

8.  Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.

Authors:  Cheng-Yang Hsieh; Chih-Hung Chen; Chung-Yi Li; Ming-Liang Lai
Journal:  J Formos Med Assoc       Date:  2013-10-18       Impact factor: 3.282

Review 9.  The link between the metabolic syndrome and cancer.

Authors:  Sandra Braun; Keren Bitton-Worms; Derek LeRoith
Journal:  Int J Biol Sci       Date:  2011-08-16       Impact factor: 6.580

10.  Epidemiologic methods of assessing asthma and wheezing episodes in longitudinal studies: measures of change and stability.

Authors:  Nelís Soto-Ramírez; Ali H Ziyab; Wilfried Karmaus; Hongmei Zhang; Ramesh J Kurukulaaratchy; Susan Ewart; Syed Hasan Arshad
Journal:  J Epidemiol       Date:  2013-08-31       Impact factor: 3.211

View more
  4 in total

1.  Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis.

Authors:  Sufian M Khaild; Amro M Fagir; Ziryab I Taha; Awadelkareem A Elshareef; Mohammed H Mohammed; Khalda M Saeed; Elnour M Elagib; Elwalied M Ibrahim; Jimmy William
Journal:  Cureus       Date:  2022-04-18

2.  Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan.

Authors:  Chang-I Chen; Jong-Shiuan Yeh; Nai-Wen Tsao; Fen-Yen Lin; Chun-Ming Shih; Kuang-Hsing Chiang; Yung-Ta Kao; Yu-Ann Fang; Lung-Wen Tsai; Wen-Chi Liu; Hironori Nakagami; Ryuichi Morishita; Yi-Jie Kuo; Chun-Yao Huang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

3.  Development of a multivariable improvement measure for gout.

Authors:  Naomi Schlesinger; N Lawrence Edwards; Anthony E Yeo; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2020-06-29       Impact factor: 5.156

4.  Exploration of Medical Trajectories of Stroke Patients Based on Group-Based Trajectory Modeling.

Authors:  Ting-Ying Chien; Mei-Lien Lee; Wan-Ling Wu; Hsien-Wei Ting
Journal:  Int J Environ Res Public Health       Date:  2019-09-18       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.